FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

329165006: Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3500943011 Hydroxyapatite 830 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4042410014 Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4042411013 Durapatite 830 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
467303017 Hydroxyapatite 830mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
720056017 Hydroxyapatite 830mg tablet (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1191731017 Hydroxyapatite 830mg tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3489573010 Product containing hydroxyapatite 830 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3491457017 Product containing hydroxyapatite 830 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3500943011 Hydroxyapatite 830 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3567213010 Product containing only hydroxyapatite 830 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3567214016 Product containing only hydroxyapatite 830 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3679650010 Product containing precisely hydroxyapatite 830 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3679651014 Product containing precisely hydroxyapatite 830 milligram/1 each conventional release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4042410014 Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4042411013 Durapatite 830 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hydroxyapatite 830 mg oral tablet Is a Product containing durapatite (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
Hydroxyapatite 830 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Mineral supplement (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Hydroxyapatite 830 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Nutrient supplementation false Inferred relationship Existential restriction modifier (core metadata concept)
Hydroxyapatite 830 mg oral tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Existential restriction modifier (core metadata concept)
Hydroxyapatite 830 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. agent pour l'appareil génito-urinaire false Inferred relationship Existential restriction modifier (core metadata concept)
Hydroxyapatite 830 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Durapatite (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Hydroxyapatite 830 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Nutritional supplement false Inferred relationship Existential restriction modifier (core metadata concept)
Hydroxyapatite 830 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Hydroxyapatite (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Hydroxyapatite 830 mg oral tablet Has manufactured dose form Conventional release oral tablet (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Hydroxyapatite 830 mg oral tablet Is a Product manufactured as oral dose form (product) false Inferred relationship Existential restriction modifier (core metadata concept)
Hydroxyapatite 830 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Hydroxyapatite (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydroxyapatite 830 mg oral tablet Has basis of strength substance (attribute) Hydroxyapatite (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydroxyapatite 830 mg oral tablet Has presentation strength numerator value 830 false Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydroxyapatite 830 mg oral tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydroxyapatite 830 mg oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydroxyapatite 830 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydroxyapatite 830 mg oral tablet Has precise active ingredient Hydroxyapatite (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydroxyapatite 830 mg oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept)
Hydroxyapatite 830 mg oral tablet Is a Hydroxyapatite-containing product in oral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
Hydroxyapatite 830 mg oral tablet Count of base of active ingredient un false Inferred relationship Existential restriction modifier (core metadata concept)
Hydroxyapatite 830 mg oral tablet Is a Calcium phosphate only product in oral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
Hydroxyapatite 830 mg oral tablet Is a Hydroxyapatite only product false Inferred relationship Existential restriction modifier (core metadata concept)
Hydroxyapatite 830 mg oral tablet Has basis of strength substance (attribute) Durapatite (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydroxyapatite 830 mg oral tablet Has precise active ingredient Durapatite (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydroxyapatite 830 mg oral tablet Is a Hydroxyapatite only product in oral dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start